Cerevel Therapeutics Holdings, Inc.
USD44.96
+0.33 (+0.74%)
CEO
Ronald C. Renaud Jr.,
IPO Date
2020-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$44.98
Prev. Close
$44.63
Day Low
$44.96
Day High
$44.99
52W Low
$19.59
52W High
$44.99
Market Cap
$8.19B
Volume
15.03M
| 10,461 |
| $0.00 |
| 5 Aug 2024 | Koppel Adam | director, 10 percent owner: | D-Return | Disposed | 65,679,781 | $45.00 |
| 5 Aug 2024 | Koppel Adam | director, 10 percent owner: | D-Return | Disposed | 80,189 | $0.00 |
| 5 Aug 2024 | Sulzberger Gabrielle | director | D-Return | Disposed | 48,415 | $45.00 |
| 5 Aug 2024 | Sulzberger Gabrielle | director | D-Return | Disposed | 10,461 | $0.00 |
| 5 Aug 2024 | Sulzberger Gabrielle | director | D-Return | Disposed | 95,242 | $0.00 |
| 5 Aug 2024 | Burgess Paul D. | See Remarks | D-Return | Disposed | 45,727 | $45.00 |
| 5 Aug 2024 | Burgess Paul D. | See Remarks | D-Return | Disposed | 95,931 | $0.00 |
| 5 Aug 2024 | Burgess Paul D. | See Remarks | D-Return | Disposed | 81,065 | $0.00 |